Breaking
● GLP-1 trial shows 34% reduction in cardiovascular events over 5 years ● Senolytics drug enters Phase III — first human trial results expected Q1 2027 ● FDA fast-tracks CRISPR base-editing therapy for sickle cell disease ● Longevity biotech index up 12% YTD as institutional capital accelerates ● AI diagnostic platform achieves 97.2% accuracy in early-stage pancreatic cancer detection ● Harvard study links CGM use to 23% lower all-cause mortality in non-diabetics
Impact Health Magazine
The GLP-1 Revolution: How Weight-Loss Drugs Are Rewriting Metabolic Medicine
Cover Story

The GLP-1 Revolution: How Weight-Loss Drugs Are Rewriting Metabolic Medicine

A $100 billion market, a paradigm shift in preventive care, and what comes next.

Read the Story
Biological Age Is No Longer a Fixed Number
Longevity

Biological Age Is No Longer a Fixed Number

Telomere science, senolytics, and the protocols reversing the clock.

Explore Longevity
The AI That Detected Cancer Before the Doctor Did
Technology & Innovation

The AI That Detected Cancer Before the Doctor Did

Deep learning models are outperforming radiologists in early detection.

Read the Analysis
Market Watch
NVO$142.30+2.4%
LLY$891.50+1.8%
ISRG$412.75-0.6%
DXCM$78.20+3.1%
MRNA$105.40-1.2%
ILMN$134.60+0.9%
Latest Articles
The GLP-1 Revolution: How Weight-Loss Drugs Are Rewriting Metabolic Medicine
Metabolic Health

The GLP-1 Revolution: How Weight-Loss Drugs Are Rewriting Metabolic Medicine

Semaglutide and tirzepatide have moved far beyond obesity treatment. Cardiologists, neurologists, and longevity researchers are now racing to understand their full systemic effects.

Dr. Sarah Chen·Sep 2026
Longevity

Live Longer. Live Better.

"The first person to live to 150 is alive today. The question is whether they know it."
150

The projected maximum human lifespan according to leading longevity researchers at the Salk Institute.

47%

Reduction in all-cause mortality seen in caloric restriction studies on non-human primates over 20 years.

$3.4B

Invested in longevity biotech in 2025 alone — a 3x increase from the prior year.

Medical Innovation

The Technology Rewriting Medicine

AI Diagnostics
AI Diagnostics

The Multimodal AI That Reads Your Blood, Genome, and Scan Simultaneously

Foundation models trained on petabytes of clinical data are synthesizing biomarker panels, genomic sequences, and imaging data into a single unified risk score.

Dr. Sarah Chen·Sep 2026
CRISPR 3.0: Base Editing Enters the Clinic
Gene Editing

CRISPR 3.0: Base Editing Enters the Clinic

Dr. Elena Vasquez·Sep 2026
The $15,000 Wearable Stack Executives Are Using
Biohacking

The $15,000 Wearable Stack Executives Are Using

Marcus Webb·Aug 2026
Wealthy Lifestyle

Wellness as a Way of Life

Leadership & Culture

The Disruptors

The Pulse

Intelligence for the Health-Conscious Elite

The Pulse delivers the week's most important breakthroughs in longevity, medical innovation, and health investing — curated for discerning readers.

No spam. Unsubscribe at any time. Read by 40,000+ executives, physicians, and investors.